Board of Directors


Susan Molineaux, Ph.D., Chair

Chief Executive Officer, Calithera Biosciences

John Melo, Vice Chair

Chief Executive Officer, Amyris, Inc.

Scott W. Morrison, Treasurer

Life Science Partner, EY

Bruce W. Jenett, Secretary

Senior Counsel, DLA Piper LLP (US)


Gregg H. Alton, J.D.

Executive Vice President, Corporate and Medical Affairs, Gilead Sciences, Inc.

Michael V. Arbige, Ph.D.

Senior Vice President, Technology
Dupont Genencor Sciences

Laura A. Brege

Chief Executive Officer, Nodality, Inc.

Peter Daly

Senior Vice President and Founding Principal, ABD Insurance and Financial Services

Gordon K. Davidson

Partner, Corporate Group and Chairman, Fenwick & West LLP

Paulette DeFalco

Western Area Life Sciences Leader, KPMG LLP

Keith Donnermeyer

Life Sciences and Healthcare Regional Managing Partner, Deloitte & Touche LLP

Kareem Dossa

Senior Vice President, Corporate Business Development

Anne-Marie Duliege, M.D., M.S.

Executive Vice President, Chief of Strategic Development & Head of Immuno-oncology
ChemoCentryx, Inc.

Steven B. Engle

Chief Executive Officer
Averigon Consulting

Paul Hastings

President and Chief Executive Officer, OncoMed Pharmaceuticals

Kristen M. Hege, M.D.

San Francisco Site Head and Vice President, Translational Development, Hematology & Oncology

Terry Hermiston, Ph.D.

Vice President, Biologics Research, U.S. Innovation Center Site Head, Bayer HealthCare Pharmaceuticals

Michael Howaldt

Senior Vice President, Biopharma Operations & Fremont Site Head
Boehringer Ingelheim

Elizabeth Howard

Partner, Intellectual Property, Orrick, Herrington & Sutcliffe LLP.

Hoyoung Huh, M.D., Ph.D.

Executive Chairman, Geron Corporation

Vera Janushkowsky

Vice President, Government Relations
Pfizer Inc.

Aarif Khakoo

Executive Director Research and Site Head, Amgen South San Francisco

David W. Martin Jr, M.D.

Chairman and Chief Executive Officer, AvidBiotics Corp.

Sean McCarthy, D. Phil.

Chief Executive Officer, CytomX

Alan Mendelson

Senior Partner and Co-Chair, Venture Technology Group, Latham & Watkins LLP

Philip Moody

Chief Operating Officer, Ventoux Pharma

William J. Newell

Chief Executive Officer, Sutro Biopharma, Inc.

John Nicols

President and Chief Executive Officer, Codexis

Jeffrey N. Peterson

Chief Executive Officer, Target Discovery, Inc

Kim Popovits

Chairman of the Board, President & CEO, Genomic Health

David W. Pritchard

David Pritchard served as Kalobios’ President and Chief Executive Officer since August 2006 until 2015. Mr. Pritchard has more than 25 years of experience in general management, business development and financial management within the biopharmaceutical industry. Prior to joining KaloBios, …

Michael G. Raab

Chief Executive Officer, Ardelyx

A. Franklin Rice

Chief Financial Officer & Vice President of Corporate Development
Epalex Corporation

Steve Richardson

Senior Vice President, Alexandria Real Estate Equities, Inc.

Howard W. Robin

President and Chief Executive Officer, NEKTAR

Terry Rosen

Chief Executive Officer, Flexus Biosciences

Una S. Ryan, Ph.D.

Managing Director, Golden Seeds (Silicon Valley)

Glen Sato

Partner, Cooley LLP

Anil Singhal

Vice President of AbbVie
Head of AbbVie Biotherapeutics Inc

Anthony Stolis

Senior Manager, Accenture

Stephen B. Thau

Partner, Morrison Foerster

Harold E. Van Wart, Ph.D.

President and Chief Executive Officer, Cymabay

William D. Young

Venture Partner, Clarus Ventures